Supermoon Capital

Sleep.ai is a leading healthtech company and the world’s most advanced sleep intelligence platform, powered by over 800 million hours of proprietary data and more than 250 scientific studies. It offers APIs, SDKs, and a consumer app that enable partners to embed clinically validated, AI-driven sleep technology into their products.

EnsoData provides AI-powered solutions for sleep disorder diagnosis and management, including cloud-based platforms for sleep study management and scoring.

Mosanna is developing an easy-to-use nighttime nasal spray to help restore the body’s natural airway control for obstructive sleep apnea patients.

Endel is a sound wellness company that creates personalized soundscapes to help users focus, relax, and sleep, utilizing patented technology that adapts in real-time to various inputs.

SleepScore Labs is a global sleep improvement company that uses patented sonar technology and science-based coaching to help users track and improve their sleep quality. The company offers a suite of services for consumers and enterprises, leveraging over 800 million hours of sleep data.

Innovators in Sleep & Circadian Science, leveraging AI digital twins to optimize sleep and health, focusing on circadian rhythms.

Aesyra develops and commercializes innovative oral appliance technology for the treatment of Sleep Bruxism, utilizing embedded sensors for monitoring and customized fitting.

Amira Software provides advanced image analysis solutions for life sciences, enabling visualization, analysis, and understanding of biomedical images with AI-driven tools.

Data-obsessed venture fund focused on infrastructure for complex, regulated or fragmented systems across continents. Pairs a small core team with a deep sector-specific advisor network including CEOs, former Nike/Uber executives, and founders, while embedding sustainability as core investment criteria.

Switzerland's first female-led VC firm with a dedicated CHF 20M fund focused specifically on women-led early-stage startups across Europe. The firm builds its investment thesis on data showing that women in leadership deliver better ROI, using this performance narrative rather than just fairness arguments as the core economic rationale for their gender-focused strategy.

Early institutional backer that sources tech from academia and government labs, partnering with scientist- and engineer-led teams to deeply interrogate science, dual-use/defense opportunities, and amplify through an in-house media platform. Explicitly aims to "turn science fiction into science fact" by backing companies at the intersection of the new and the not-yet-imagined, built around scientists, engineers, and polymaths rather than traditional finance backgrounds who can deeply interrogate emerging science and complex tech. The firm systematically mines academia and government labs for "technological gems" and has become one of the earliest institutional backers of dual-use and defense technology.

Pre-seed lead investor for deeply technical AI, biotech, climatetech and infrastructure startups, offering female operator-led go-to-market expertise and structured fellowships to source technical-founder deal flow. Divergent Capital is run by two female operator-investors who combine deep-tech investing experience with hands-on go-to-market expertise, and they cultivate deal flow through structured fellowships targeting students and emerging investors in their technical-founder network.

Jazz is a venture capital fund built entirely around human performance that invests only in technologies optimizing human health, productivity, and well-being, with a core thesis explicitly tying advances in neuroscience and brain science to behavior change. The team includes practicing scientists, neurosurgeons, and technologists, giving them primary research insight and technical diligence depth that most generalist venture firms lack.